⌘K

Login Start Free

Home/Filings/4/0001567619-19-007726

4//SEC Filing

CATELL ROBERT B 4

Accession 0001567619-19-007726

CIK 0001505497other

View on SEC.gov Company Profile

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 5:11 PM ET

Size

28.1 KB

Accession

0001567619-19-007726

Insider Transaction Report

Form 4

Period: 2019-03-25

BioRestorative Therapies, Inc.BRTX

CATELL ROBERT B

Director

Transactions

Award
Stock Option
2019-03-25+15,000→ 15,000 total
Exercise: $0.75Exp: 2026-02-19→ Common Stock (15,000 underlying)
Award
Stock Option
2019-03-25+75,000→ 75,000 total
Exercise: $0.75Exp: 2028-10-29→ Common Stock (75,000 underlying)
Award
Stock Option
2019-03-25+29,000→ 29,000 total
Exercise: $0.75Exp: 2026-06-10→ Common Stock (29,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−15,000→ 0 total
Exercise: $3.70Exp: 2026-02-19→ Common Stock (15,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−100,000→ 0 total
Exercise: $3.35Exp: 2027-06-23→ Common Stock (100,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−75,000→ 0 total
Exercise: $1.23Exp: 2028-10-29→ Common Stock (75,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−29,000→ 0 total
Exercise: $3.73Exp: 2026-06-10→ Common Stock (29,000 underlying)
Award
Stock Option
2019-03-25+100,000→ 100,000 total
Exercise: $0.75Exp: 2027-06-23→ Common Stock (100,000 underlying)

Holdings

Warrant
Exercise: $5.00From: 2016-03-01Exp: 2021-03-01→ Common Stock (37,500 underlying)
37,500
Warrant
Exercise: $4.00From: 2016-08-05Exp: 2021-08-05→ Common Stock (8,000 underlying)
8,000
Warrant
Exercise: $4.00From: 2017-03-01Exp: 2022-03-01→ Common Stock (15,000 underlying)
15,000
Warrant
Exercise: $4.00From: 2017-02-10Exp: 2022-02-10→ Common Stock (10,866 underlying)
10,866
Warrant
Exercise: $4.00From: 2017-08-11Exp: 2022-08-11→ Common Stock (5,000 underlying)
5,000
Common Stock
80,866
Warrant
Exercise: $5.00From: 2016-05-18Exp: 2021-05-18→ Common Stock (12,500 underlying)
12,500

Footnotes (5)

[F1]The option vests to the extent of 5,000 shares on each of February 19, 2017, 2018 and 2019.
[F2]The option vests to the extent of 9,667 shares on each of June 10, 2016 and June 10, 2017, and 9,666 shares on June 10, 2018.
[F3]The option is exercisable to the extent of 33,334 shares on June 23, 2017, and 33,333 shares on each of June 23, 2018 and June 23, 2019.
[F4]The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020.
[F5]The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

BioRestorative Therapies, Inc.

CIK 0001505497

Entity typeother

Related Parties

1

filerCIK 0001195325

Filing Metadata

Form type: 4
Filed: Mar 26, 8:00 PM ET
Accepted: Mar 27, 5:11 PM ET
Size: 28.1 KB

View on SEC.gov